Efficacy and Safety of Non-Vitamin K Anticoagulants for Atrial Fibrillation in Relation to Different Renal Function Levels: A Network Meta-Analysis

<div>Brooks-Gelman-Rubin diagnostic plot and density plot for the efficacy of the comparison among different treatments of patients with normal renal function (A: warfarin; B: dabigatran110; C: dabigatran150; D: edoxaban30; E: edoxaban60; F:apixaban; G:rivaroxaban).</div>

Cardiovascular Therapeutics

fig2

Figure 2

Figure 2: Efficacy and Safety of Non-Vitamin K Anticoagulants for Atrial Fibrillation in Relation to Different Renal Function Levels: A Network Meta-Analysis 

Figure 2 | Efficacy and Safety of Non-Vitamin K Anticoagulants for Atrial Fibrillation in Relation to Different Renal Function Levels: A Network Meta-Analysis 